The European Medicines Agency (EMA) has released for public consultation an open call for data on use of antimicrobials in animal

 Published: 08 Jan 2020 | Last Updated: 08 Jan 2020 07:59

The European Medicines Agency (EMA) has released for public consultation an open call for data on use of antimicrobials in animals.

Regulation (EU) 2019/6 on veterinary medicinal products, which sets the future regulatory framework for veterinary medicines, provides a wide range of concrete measures to fight antimicrobial resistance and to promote the prudent use of antimicrobials. Such measures include, in particular, the possibility to reserve certain antimicrobials for treatment of certain human infections only, in order to preserve their efficacy.

The European Commission has asked the EMA to provide scientific advice on how these provisions could best be addressed in forthcoming additional legislation.

In order to support the EMA in the preparation of its scientific advice, the CVMP invites all interested parties, such as pharmaceutical industry, veterinarians, professional groups, learned societies, governmental institutions as well as EU and EEA Member States to submit information on cascade use of antimicrobials in animals and any scientific evidence of an impact on public and animal health that the CVMP should consider.

We kindly ask you to respond to the questions by filling in the questionnaire: https://ec.europa.eu/eusurvey/runner/OpenCallUseofantimicrobialsinanimals (please note, that these questions relate to EU practices only).

Please provide details of your area of work (e.g. veterinarian and type of practice, industry, professional body) and country where you are located at the top of the template. Please note that your responses will be considered anonymously. The data collected will be used to inform the advice provided to the Commission on the Implementing Acts under the new Regulation 2019/6. It may be included in the report in an aggregated format.

The call is open until 6 March 2020. For more details, please consult the open call, which includes the list of questions.

For more information on the European regulatory system for medicines, please click here (brochure available in all languages).